What is the KY-ODCP?
The Office of Drug Control Policy is tasked to coordinate Kentucky’s response to substance abuse. Our goal is to change the way substance abuse is handled in Kentucky, reducing the problem, and making the Commonwealth a model for other states. We have joined prevention/education, treatment, and law enforcement in a united effort to confront this epidemic and have made great strides. As we plan for the future, we know the success of our initiatives depends on the involvement and support of grassroots coalitions, local and state agencies, as well as community and faith-based organizations throughout Kentucky.
2014 Combined Annual Report: Kentucky Office of Drug Control Policy & Kentucky Agency For Substance Abuse Policy
2014 annual report FINAL.pdf
2014 Overdose Fatality Report:
2014- ODCP Overdose Death Report final1.pdf
House Bill 1 Evaluation Study Results:
The University of Kentucky, Institute for Pharmaceutical Outcomes and Policy completed an evaluation of the impact of House Bill 1 passed during the special session of the 2012 Kentucky Legislature. Following is the executive summary of the study and the full study report. For all other information, please visit the KASPER web page.
House Bill 1 Evaluation Study Executive Summary
House Bill 1 Impact Evaluation
Proposals Now Being Accepted for Senate Bill 192
Treatment Grants to Address Neonatal Abstinence Syndrome (NAS)
It is well established that Kentucky has a significant
public health crisis with regards to substance use disorder, particularly
prescription and illicit opiates. The Commonwealth has seen a substantial
increase in opiate use, a significant increase in the number of babies born
with NAS, and an increase in blood-borne diseases from intravenous drug use,
including Hepatitis C and HIV. The
funding from SB 192 will help the state address these problems.
The Kentucky Agency for Substance Abuse Policy (KY-ASAP), through
a partnership with the Kentucky Department for Behavioral Health, Developmental
and Intellectual Disabilities, is currently accepting SB192 grant proposals to
address neonatal abstinence syndrome (NAS). This bill allows up to $1 million
in funding to substance use treatment providers to address Neonatal Abstinence
Syndrome (NAS) by offering comprehensive residential treatment services to
pregnant women who have opiate dependency through programs that employ
evidence-based behavioral health treatment or medically-assisted treatment.
Grant Application Materials can be accessed at:
SB192 Funding Opportunity_Memo to Providers1.pdf
SB192_NAS Proposal Guidelines.pdf
SB 192 Funding Budget Detail_NAS.pdf
SB 192 funding compliance statement_NAS.pdf
Meetings, Trainings, and Conferences:
2014 KY-ASAP State Board Meeting Dates~
*August 20, 2015
*November 19, 2015
All meetings begin at 11:00 a.m. and will be held in the First Floor Conference Room of the Justice and Public Safety Building, 125 Holmes Street, Frankfort, KY. For more information, please contact Heather Wainscott at 502.564.8277
A powerful PSA by students of The Performer's Academy on the prescription drug and heroin epidemic in this country, Every 19 minutes we lose one life to an rx overdose. The face of today's heroin addict is quite different from years ago. The national age of overdosing is between 18-25 years of age. Please get informed.